Angelo Dipasquale

9PUBLICATIONS
41CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsChemotherapyLiquid biopsiesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 13, 2025
Case study: Successful full-course chemotherapy administration in a liver transplant recipient diagnosed with central nervous system World Health Organization Grade 2 IDH mutant/1p-19q co-deleted oligodendroglioma.

Angelo Dipasquale, Agnese Losurdo, Pasquale Persico

|May 14, 2025
Exploring the Role of ADCs in Brain Metastases and Primary Brain Tumors: Insight and Future Directions.

Francesco Bruzzone, Chiara Barigazzi, Antonio Di Muzio

|Feb 10, 2024
T Cell Features in Glioblastoma May Guide Therapeutic Strategies to Overcome Microenvironment Immunosuppression.

Agnese Losurdo, Antonio Di Muzio, Beatrice Claudia Cianciotti

|Feb 05, 2024
Vorasidenib in IDH mutant WHO grade 2 gliomas: time to stop sitting on the fence?

Angelo Dipasquale, Enrico Franceschi, Giuseppe Lombardi

|Jan 17, 2023
Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation.

Francesca Orzan, Francesca De Bacco, Elisabetta Lazzarini

|May 28, 2022
Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter Study.

Mario Caccese, Matteo Simonelli, Veronica Villani

Pageof 2

Frequent Collaborators

8 joint publications

Matteo Simonelli

6 joint publications

Pasquale Persico

3 joint publications

Armando Santoro

3 joint publications

Giuseppe Lombardi